Mathews Open Access Journals follow certain ethical standards to make sure high-quality scientific publications, to attain public confidence in scientific findings.
Plagiarism/ Duplicate Submission: Mathews Open Access Journals firmly encourages original manuscripts and must not use the words, figures, or ideas of others without attribution. All sources must be cited at the point they are used, and reuse of wording must be limited and be attributed or quoted in the text. The content should not be submitted/ published elsewhere with other publishing groups. Our quality control teams check for the plagiarism through software to detect the overlapping of content and similar text in submitted manuscripts. Manuscripts that are found to have been plagiarized from a manuscript by other authors, whether published or unpublished, will be rejected and the authors may incur sanctions. Any published articles may need to be corrected or retracted.
Data Fabrication and Falsification: If the submitted manuscripts are found to have either fabricated or falsified research work, i.e. methods, experimental results, including the manipulation of images will be immediately rejected.
Conflicts of Interest: Authors must declare all potential interests in a ‘Conflicts of interest’ section, which should explain why the interest may be a conflict. If there are none, the authors should state “The author(s) declare(s) that there are no conflicts of interest regarding the publication of this paper.” Submitting authors are responsible for coauthors declaring their interests.
Human and Animal Rights: Ethical clearance documents need to be provided if applicable. The work involving animal models and human volunteers need to submit the necessary statements.
In the above publication ethical cases if the violations are found, the editorial office is authorized to take action accordingly.
Published : 05th July 2024
Authors : Ezegbe Chekwube Andrew1,4,* Anikwe Celestine Chidera2, Uzondu Samuel WisdomofGod3,4, Okorie James Ekemezie1, Okafor Nnedimma Pauline1, Ezegbe Amarachi Grace5, Agu Kenechukwu Christian1, Okorafor Ezinne Chinemerem6, Aniagwu Ifunanya Sheila1
Citation : Andrew EC, et al. (2024). Formulation and in Vitro Evaluation of Liquisolid Compact of Celecoxib. Mathews J Pharma Sci. 8(2):31.
Published : 02nd July 2024
Authors : Vaibhav Adhao*, Jaya Ambhore, Anant Bhuskat, Dishali Talokar
Citation : Adhao V, et al. (2024). A Review on Analytical Methodologies for the Estimation of Anti-Retroviral Drugs Cabotegravir and Rilpivirine. Mathews J Pharma Sci. 8(1):30.
Published : 28th June 2024
Authors : Paolo Zanirato1,*, Silvia Businelli2
Citation : Zanirato P, et al. (2024). Synthesis and Antidiseas Evaluation of Some Bis-Heteroaryls (Thiophene or Selenophene) 1,2,3-triazoles C-trimethylsilylated. Mathews J Pharma Sci. 8(1):29.
Published : 13th June 2024
Authors : Amarachi Salome Chime1, Chekwube Andrew Ezegbe1,3,* Chidinma Judith Iyanyi1, Chukwunwike Godswill Onunkwo1, Amarachi Grace Ezegbe2, Nnedimma Pauline Okafor1
Citation : Chime AS, et al. (2024). Formulation, In-Vitro and In-Vivo Evaluation of Lamivudine-Loaded Solid Lipid Nanoparticles (SLNs). Mathews J Pharma Sci. 8(1):28.
Published : 18th May 2024
Authors : Ferruccio Trifirò*, Paolo Zanirato#
Citation : Trifirò F, et al. (2024). The Battle of the Physic and Chemistry against Pathogenic Microorganism. Mathews J Pharma Sci. 8(1):27.
Published : 01st April 2024
Author : Marjan Dzeparoski1,2,*
Citation : Dzeparoski M. (2024). Regulatory Update on eSubmissions in Balkans. Mathews J Pharma Sci. 8(1):26.